Minerva Neurosciences Inc [NERV] stock is trading at $2.18, up 1.89%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NERV shares have gain 3.56% over the last week, with a monthly amount glided 0.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Minerva Neurosciences Inc [NASDAQ: NERV] stock has seen the most recent analyst activity on June 08, 2020, when H.C. Wainwright reiterated its Buy rating and also revised its price target to $10 from $20. Previously, BTIG Research started tracking the stock with Buy rating on May 14, 2020, and set its price target to $23. On October 02, 2019, Chardan Capital Markets reiterated its Buy rating but maintained its price target of $17 on the stock. Chardan Capital Markets started tracking the stock assigning a Buy rating and suggested a price target of $17 on September 25, 2019. William Blair initiated its recommendation with a Outperform. In a note dated September 01, 2017, Citigroup initiated an Buy rating and provided a target price of $11 on this stock.
Minerva Neurosciences Inc [NERV] stock has fluctuated between $1.15 and $2.83 over the past year. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Minerva Neurosciences Inc [NASDAQ: NERV] shares were valued at $2.18 at the most recent close of the market. An investor can expect a potential return of 129.36% based on the average NERV price forecast.
Analyzing the NERV fundamentals
Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -382.92%, Pretax Profit Margin comes in at 265.99%, and Net Profit Margin reading is 265.99%. To continue investigating profitability, this company’s Return on Assets is posted at 0.37, Equity is -0.0 and Total Capital is -0.58. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.14 points at the first support level, and at 2.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.20, and for the 2nd resistance point, it is at 2.22.
Ratios To Look Out For
For context, Minerva Neurosciences Inc’s Current Ratio is 6.15. As well, the Quick Ratio is 6.15, while the Cash Ratio is 6.03.
